Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lawrence H. Einhorn, MD
Indiana University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospital
Pretoria, South Africa
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (lakeside)
Chicago, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Kimball Medical Center
Lakewood, New Jersey, United States
- Morristown Memorial Hospital
Morristown, New Jersey, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- Ccop - Marshfield Medical Research and Education Foundation
Marshfield, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jan 1999
- Primary completion
- 31 Jul 2002
- Completion
- —
- Last update posted
- 22 Jun 2023
- Registered enrollment
- 44
- Registry id
- NCT00003518
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.